Leading global biopharmaceutical firm AstraZeneca has suspended expansion in the Chinese generic drug market. It announced adjustments on strategy for business in the Chinese mainland days ago and according to the adjustments, it will ...
Tags: Generic Drug Market, Health, Medicine